Tourmaline Bio, Inc.
SEC CIK 1827506 · TRML · last insider filing 2025-10-28
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Siegall Clay B | Director | filed 2023 - 2025 |
| Mcdade Mark | Director | filed 2021 - 2025 |
| Castelein Caley | Director | filed 2023 - 2025 |
| Srivastava Sapna | Director | filed 2021 - 2025 |
| Kantoff Aaron | Director | filed 2023 - 2025 |
| Kulkarni Sandeep Chidambar | Director · CEO | filed 2023 - 2025 |
| Thiara Parvinder | Director | filed 2023 - 2025 |
| Chester Cariad | Director | filed 2023 - 2023 |
| Requadt Scott | Director · See Remarks | filed 2021 - 2023 |
| Nader Francois | Director | filed 2021 - 2023 |
| Smith Karen L. | Director | filed 2022 - 2023 |
| Shah Gaurav | Director | filed 2021 - 2023 |
| Mackay Geoffrey | Director | filed 2021 - 2023 |
| Ildstad Suzanne | Director · Chief Scientific Officer | filed 2021 - 2023 |
| Agarwala Sandip | Director | filed 2021 - 2023 |
| Galakatos Nicholas | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Middlekauff W Bradford | CBO, GC and Secretary | filed 2023 - 2025 |
| Johnson Kevin Bruce | Chief Regulatory Officer | filed 2023 - 2025 |
| Jones Susan Dana | Chief Technology Officer | filed 2023 - 2025 |
| Robinson Ryan F. | Interim CFO | filed 2023 - 2025 |
| Chyung Yung H. | Chief Medical Officer | filed 2023 - 2023 |
| Fenton Mary Kay | Chief Financial Officer | filed 2021 - 2023 |
| Zdanowski Michael | Chief Technology Officer | filed 2021 - 2023 |
| Krieger Nancy | Chief Medical Officer | filed 2021 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.